Pyruvate mitigates oxidative stress during reperfusion of cardioplegia-arrested myocardium. 2006

E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth, Texas 76107-2699, USA.

BACKGROUND Cardioplegic arrest and reperfusion of the myocardium imposes oxidative stress that could potentially inactivate metabolic enzymes and compromise energy production. This study determined the impact of cardioplegic arrest and reperfusion on activities of several oxidant-sensitive enzymes, and tested whether pyruvate, a natural metabolic fuel and antioxidant, mitigates oxidant stress, protects enzymes, and bolsters myocardial energy state after reperfusion. METHODS In situ swine hearts were arrested for 60 minutes with 4:1 blood:crystalloid cardioplegia, and then reperfused for 3 minutes with cardioplegia-free blood with or without approximately 12 mM pyruvate. Tissue metabolites and enzyme activities were measured in left ventricular myocardium snap frozen at 45 minutes of arrest and 3 minutes of reperfusion. RESULTS The 8-isoprostane content, a measure of lipid peroxidation, sharply increased upon reperfusion, coincident with a 70% decline in redox state of the intracellular antioxidant glutathione. Aconitase and glucose 6-phosphate dehydrogenase activities fell during arrest; creatine kinase and phosphofructokinase were inactivated upon reperfusion. Pyruvate suppressed 8-isoprostane formation, maintained glutathione redox state, and enhanced phosphocreatine phosphorylation potential, a measure of myocardial energy state, during reperfusion. Pyruvate reactivated creatine kinase and aconitase, which are at least partially mitochondrial enzymes, but did not protect the cytosolic enzymes glucose 6-phosphate dehydrogenase and phosphofructokinase. CONCLUSIONS Administration of pyruvate upon reperfusion after cardioplegic arrest mitigates oxidative stress, protects mitochondrial enzymes and increases myocardial energy state. These results support therapeutic application of pyruvate-enhanced reperfusion to prevent cardiac injury after cardioplegic arrest.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D019289 Pyruvic Acid An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed) Pyruvate,Acid, Pyruvic
D023421 Models, Animal Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing. Experimental Animal Models,Laboratory Animal Models,Animal Model,Animal Model, Experimental,Animal Model, Laboratory,Animal Models,Animal Models, Experimental,Animal Models, Laboratory,Experimental Animal Model,Laboratory Animal Model,Model, Animal,Model, Experimental Animal,Model, Laboratory Animal,Models, Experimental Animal,Models, Laboratory Animal

Related Publications

E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
March 1998, Free radical biology & medicine,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
January 2013, Molecular vision,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
January 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
January 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
July 2019, European review for medical and pharmacological sciences,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
February 2023, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
July 1984, The Journal of thoracic and cardiovascular surgery,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
April 1992, Molecular and cellular biochemistry,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
April 2004, Current opinion in pharmacology,
E Marty Knott, and Jie Sun, and Yu Lei, and Myoung-Gwi Ryou, and Albert H Olivencia-Yurvati, and Robert T Mallet
April 1995, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!